Opinion

Davis v. Wyeth Laboratories, Inc.

  • 399 F.2d 121
Court
Court of Appeals for the Ninth Circuit
Filed
Jan 22, 1968
Status
Published
Author
Hamlin
On the bench
Hamlin, Merrill
Cited by
142 cases

holding that prescription drug manufacturer may have a duty to see that warnings of the drug’s risks, distributed to the medical profession, in fact reached the drug’s ultimate consumers

How later courts described this case

  • holding that prescription drug manufacturer may have a duty to see that warnings of the drug’s risks, distributed to the medical profession, in fact reached the drug’s ultimate consumers
  • holding that prescription drug manufacturer may have duty to see that warnings of drug’s risks, distributed to medical profession, in fact reached drug’s ultimate consumers
  • the difference between implied warranty and strict liability in tort “is largely one of terminology”
  • in case of polio vaccine which was denominated a prescription drug but was not dispensed as such, warning by manufacturer to its immediate purchaser did not suffice

Written by the judges who cited it.

Distinguished

  • Distinguished by Mazur v. Merck & Co., 964 F.2d 1348 (1992)

    The defendant argued that it met its duty to warn by inserting an adequate warning — the package circular — in the vials of vaccine, and that Davis was distinguishable because (1) whereas the plaintiff in Davis was vaccinated as part of a mass immunization program, the plaintiff in Reyes was vaccinated at her parents’ request; (2) whereas the plaintiff in Davis was vaccinated by a pharmacist, the plaintiff in Reyes w…
    Court of Appeals for the Third CircuitMay 20, 1992Read it
  • Distinguished by Bacardi v. Holzman, 182 N.J. Super. 422 (1981)

    Davis and Reyes are clearly distinguishable.
    New Jersey Superior Court Appellate DivisionDec 30, 1981Read it
  • Distinguished by Reyes v. Wyeth Laboratories, 498 F.2d 1264 (1974)

    Were we to conclude that Wyeth neither knew nor had reason to know that its vaccine would be dispensed without prescription drug safeguards, we might be required to hold that the rationale in Davis is inapplicable here.
    Court of Appeals for the Fifth CircuitJul 31, 1974Read it

The opinion

HAMLIN, Circuit Judge

(dissenting).

I respectfully dissent.

Appellee brought to the attention of the Medical Society the report of the Surgeon General. After this, the Medical Society, which was in charge of the mass immunization program, decided to proceed and the program was thereafter under the direction of that organization. On each of the bottles containing 100 doses of that vaccine which appellee sold to the Medical Society, appellee included a printed insert containing pertinent portions of the Surgeon General’s report. Under the circumstances of this case I cannot agree with the court’s holding that there was as a matter of law an *132 absolute breach by appellee of its duty to warn.

The court’s instruction to the jury that there was an implied warranty on the part of appellee that the vaccine was reasonably fit for the particular purpose for which it was manufactured was proper, and the jury verdict in favor of ap-pellee apparently found that there was no breach of that warranty.

I would affirm.

HAMLIN, Circuit Judge, would grant the petition for rehearing.

This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.

A word about cookies

We need a few to keep you signed in and the library working. The rest help us see which pages people use and where they get stuck. They stay off unless you say yes.